Alice Medalia1, Julie Thysen. 1. Department of Psychiatry, Columbia University College of Physicians and Surgeons, 180 Fort Washington Ave, HP234, New York, NY 10032, USA. am2938@columbia.edu
Abstract
BACKGROUND: Schizophrenia is associated with neuropsychological deficits that have been linked to poor functional outcome. To address this problem, pharmacologic and behavioral treatments are being developed for cognitive impairments, but they will not be well utilized if people with schizophrenia do not perceive a need for treatment. AIMS: This study compared whether people with schizophrenia have a similar degree of insight into neuro-cognitive symptoms as clinical symptoms, and whether neuro-cognitive and clinical symptoms are similarly related to degree of insight into these two aspects of the illness. METHOD: Seventy-one patients with schizophrenia were administered measures of clinical and neuro-cognitive status as well as clinician rated measures of insight into clinical and neuro-cognitive symptoms. RESULTS: Patients had significantly less insight into their neuro-cognitive symptoms than their clinical symptoms. On average, patients had good insight into clinical symptoms and partial insight into neuro-cognitive symptoms. Neuropsychological variables were related to insight into clinical symptoms, but not insight into neuro-cognition. Clinical variables were not significantly related to either type of insight. CONCLUSIONS: Insight is not a unitary concept and the differences between awareness of neuro-cognition and awareness of clinical symptoms suggest that they have to be addressed separately in treatment. Specific education about cognitive symptoms may be necessary to improve awareness of this aspect of the schizophrenia. Copyright (c) 2009 Elsevier B.V. All rights reserved.
BACKGROUND:Schizophrenia is associated with neuropsychological deficits that have been linked to poor functional outcome. To address this problem, pharmacologic and behavioral treatments are being developed for cognitive impairments, but they will not be well utilized if people with schizophrenia do not perceive a need for treatment. AIMS: This study compared whether people with schizophrenia have a similar degree of insight into neuro-cognitive symptoms as clinical symptoms, and whether neuro-cognitive and clinical symptoms are similarly related to degree of insight into these two aspects of the illness. METHOD: Seventy-one patients with schizophrenia were administered measures of clinical and neuro-cognitive status as well as clinician rated measures of insight into clinical and neuro-cognitive symptoms. RESULTS:Patients had significantly less insight into their neuro-cognitive symptoms than their clinical symptoms. On average, patients had good insight into clinical symptoms and partial insight into neuro-cognitive symptoms. Neuropsychological variables were related to insight into clinical symptoms, but not insight into neuro-cognition. Clinical variables were not significantly related to either type of insight. CONCLUSIONS: Insight is not a unitary concept and the differences between awareness of neuro-cognition and awareness of clinical symptoms suggest that they have to be addressed separately in treatment. Specific education about cognitive symptoms may be necessary to improve awareness of this aspect of the schizophrenia. Copyright (c) 2009 Elsevier B.V. All rights reserved.
Authors: Felicia Gould; Laura Stone McGuire; Dante Durand; Samir Sabbag; Carlos Larrauri; Thomas L Patterson; Elizabeth W Twamley; Philip D Harvey Journal: Neuropsychology Date: 2015-02-02 Impact factor: 3.295
Authors: Samir Sabbag; Elizabeth W Twamley; Lea Vella; Robert K Heaton; Thomas L Patterson; Philip D Harvey Journal: Schizophr Res Date: 2012-03-02 Impact factor: 4.939
Authors: Philip D Harvey; Elizabeth W Twamley; Amy E Pinkham; Colin A Depp; Thomas L Patterson Journal: Schizophr Bull Date: 2017-05-01 Impact factor: 9.306